Revolutionize Collaboration and Supercharge Productivity

健友股份(603707)6月27日晚间公告，公司全资子公司香港健友（被许可方代表）及香港健友控股子公司Meitheal（被许可方）拟与Xentria签署许可协议，Xentria授予被许可方 ... ... Meitheal（被许可方）拟与Xentria签署许可协议，Xentria授予被许可方在许可区域开发和商业化XTMAB的独占许可，并向被许可方/被许可方代表转让与XTMAB相关的专利、技术 ... Popular SearchesXentria IncXentria Corporation LtdXentria Group of Companies LtdXentria ... Xentria and Meitheal Pharmaceuticals Announce Exclusive Licensing ... Xentria landed a nearly $700 million licensing agreement with Meitheal Pharmaceuticals, a local drugmaker that spun out Xentria in 2020. Read ... Prior to joining Xentria and Meitheal, Tom was Vice President of Global Alliance Management for Sagent Pharmaceuticals and was responsible for global ... Tom Shea, Chief Executive Officer at Meitheal Pharmaceuticals, based in Chicago, United States. Previously, he served as Chief Executive Officer of Xentria. 格隆汇6月27日丨健友股份(603707.SH)公布，公司全资子公司香港健友及香港健友控股子公司Meitheal拟与Xentria签署《许可协议》，Xentria授予被许可方在 ... News (Medical) associated with Xentria, Inc. 19 Jul 2024. ·firstwordpharma.com · Meitheal taps Nabriva's ... Meitheal is proud to be partnered with Xentria on XTMAB-16! #xentria #XTMAB16 #pulmonarysarcoidosis. Xentria and Meitheal Pharmaceuticals announce exclusive licensing agreement for XTMAB-16 in North America · Spotlight · Meitheal is Ranked #4 on Crain's 2023 ...